Collaboration - May 4, 2015
Recipharm, Follicum Ink Pact
Recipharm has signed an agreement of cooperation with Follicum AB prior to a clinical trial for the drug candidate FOL-005th, which is being developed to stimulate or inhibit hair growth for both men and women, without side effects. Recipharm has been commissioned to formulate and produce the product that will be used in the clinical […]
Pharma Business - April 16, 2015
Recipharm Invests in Synthonics
Recipharm has made an equity investment in Synthonics Inc. and purchased $2.0 million of preferred stock in the company. An additional $2.0 million of preferred stock is expected to be purchased upon Synthonics’ achievement of certain milestones, which could occur during 2016, according to information from Recipharm. Synthonics and Recipharm also have entered into a […]
Pharma Business - March 11, 2015
Recipharm Creates New Position
Recipharm has appointed Thomas Beck to a new position, vice president, quality management, effective April 1, 2015. Since 2010 Beck has been head of quality control and assurance – quality manager for Recipharm. He is also president of the pharmaceutical section for quality assurance. Beck’s duties will include leading and coordinating quality strategy and policy […]
Companies - December 5, 2014
Meda to Stop Making Penicillin in Sweden
Meda, one of Recipharm’s customers, has today advised that it will transfer supply of its mainly Swedish penicillin products and manufacture offshore with other suppliers. The manufacturing contract with Recipharm Strängnäs will be terminated on Dec. 31, 2015. This business accounts for approximately 2% of Recipharm’s current sales. Recipharm currently employs 60 employees in Strängnäs and unfortunately the […]
Pharma Business - October 20, 2014
Recipharm to be divided
The main shareholders are implementing a division of their shareholdings in Recipharm. B&E Participation AB owns 12,685,716 shares series A and 3,892,407 shares series B in Recipharm, corresponding to approximately 46 percent of the capital and about 86 percent of the votes. Backsell Eldered Holding AB owns all the shares in B&E Participation AB. Lars […]
Financing - September 22, 2014
Recipharm secures financing
The company has entered a new five-year SEK 1 500 million loan facility with three of the largest banks in Scandinavia for continued growth. The revolving credit facility of SEK 1 500 million is signed with DNB, Handelsbanken and Swedbank and will serve as an additional resource to facilitate future expansion plans set in place for the business, […]
